1 Study Coverage 1.1 H2-Receptor Antagonists Product Introduction 1.2 Market by Type 1.2.1 Global H2-Receptor Antagonists Market Size Growth Rate by Type 1.2.2 Ranitidine/Zantac 1.2.3 Cimetidine 1.2.4 Famotidine 1.2.5 Nazatidine 1.3 Market by Application 1.3.1 Global H2-Receptor Antagonists Market Size Growth Rate by Application 1.3.2 Retail Stores 1.3.3 Clinics 1.3.4 Hospitals 1.3.5 OTC Sales 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global H2-Receptor Antagonists Market Size, Estimates and Forecasts 2.1.1 Global H2-Receptor Antagonists Revenue 2016-2027 2.1.2 Global H2-Receptor Antagonists Sales 2016-2027 2.2 Global H2-Receptor Antagonists, Market Size by Region: 2016 VS 2021 VS 2027 2.3 H2-Receptor Antagonists Historical Market Size by Region (2016-2021) 2.3.1 Global H2-Receptor Antagonists Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global H2-Receptor Antagonists Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 H2-Receptor Antagonists Market Estimates and Projections by Region (2022-2027) 2.4.1 Global H2-Receptor Antagonists Sales Forecast by Region (2022-2027) 2.4.2 Global H2-Receptor Antagonists Revenue Forecast by Region (2022-2027) 3 Global H2-Receptor Antagonists Competitor Landscape by Players 3.1 Global Top H2-Receptor Antagonists Manufacturers by Sales 3.1.1 Global H2-Receptor Antagonists Sales by Manufacturer (2016-2021) 3.1.2 Global H2-Receptor Antagonists Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top H2-Receptor Antagonists Manufacturers by Revenue 3.2.1 Key H2-Receptor Antagonists Manufacturers Covered: Ranking by Revenue 3.2.2 Global H2-Receptor Antagonists Revenue by Manufacturers (2016-2021) 3.2.3 Global H2-Receptor Antagonists Revenue Share by Manufacturers (2016-2021) 3.2.4 Global H2-Receptor Antagonists Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by H2-Receptor Antagonists Revenue in 2020 3.2.6 Global H2-Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global H2-Receptor Antagonists Price by Manufacturers 3.4 Global H2-Receptor Antagonists Manufacturing Base Distribution, Product Types 3.4.1 H2-Receptor Antagonists Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers H2-Receptor Antagonists Product Type 3.4.3 Date of International Manufacturers Enter into H2-Receptor Antagonists Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global H2-Receptor Antagonists Market Size by Type (2016-2021) 4.1.1 Global H2-Receptor Antagonists Sales by Type (2016-2021) 4.1.2 Global H2-Receptor Antagonists Revenue by Type (2016-2021) 4.1.3 H2-Receptor Antagonists Average Selling Price (ASP) by Type (2016-2021) 4.2 Global H2-Receptor Antagonists Market Size Forecast by Type (2022-2027) 4.2.1 Global H2-Receptor Antagonists Sales Forecast by Type (2022-2027) 4.2.2 Global H2-Receptor Antagonists Revenue Forecast by Type (2022-2027) 4.2.3 H2-Receptor Antagonists Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global H2-Receptor Antagonists Market Size by Application (2016-2021) 5.1.1 Global H2-Receptor Antagonists Sales by Application (2016-2021) 5.1.2 Global H2-Receptor Antagonists Revenue by Application (2016-2021) 5.1.3 H2-Receptor Antagonists Price by Application (2016-2021) 5.2 H2-Receptor Antagonists Market Size Forecast by Application (2022-2027) 5.2.1 Global H2-Receptor Antagonists Sales Forecast by Application (2022-2027) 5.2.2 Global H2-Receptor Antagonists Revenue Forecast by Application (2022-2027) 5.2.3 Global H2-Receptor Antagonists Price Forecast by Application (2022-2027) 6 United States by Players, Type and Application 6.1 United States H2-Receptor Antagonists Market Size YoY Growth 2016-2027 6.1.1 United States H2-Receptor Antagonists Sales YoY Growth 2016-2027 6.1.2 United States H2-Receptor Antagonists Revenue YoY Growth 2016-2027 6.1.3 United States H2-Receptor Antagonists Market Share in Global Market 2016-2027 6.2 United States H2-Receptor Antagonists Market Size by Players (International and Local Players) 6.2.1 United States Top H2-Receptor Antagonists Players by Sales (2016-2021) 6.2.2 United States Top H2-Receptor Antagonists Players by Revenue (2016-2021) 6.3 United States H2-Receptor Antagonists Historic Market Review by Type (2016-2021) 6.3.1 United States H2-Receptor Antagonists Sales Market Share by Type (2016-2021) 6.3.2 United States H2-Receptor Antagonists Revenue Market Share by Type (2016-2021) 6.3.3 United States H2-Receptor Antagonists Price by Type (2016-2021) 6.4 United States H2-Receptor Antagonists Market Estimates and Forecasts by Type (2022-2027) 6.4.1 United States H2-Receptor Antagonists Sales Forecast by Type (2022-2027) 6.4.2 United States H2-Receptor Antagonists Revenue Forecast by Type (2022-2027) 6.4.3 United States H2-Receptor Antagonists Price Forecast by Type (2022-2027) 6.5 United States H2-Receptor Antagonists Historic Market Review by Application (2016-2021) 6.5.1 United States H2-Receptor Antagonists Sales Market Share by Application (2016-2021) 6.5.2 United States H2-Receptor Antagonists Revenue Market Share by Application (2016-2021) 6.5.3 United States H2-Receptor Antagonists Price by Application (2016-2021) 6.6 United States H2-Receptor Antagonists Market Estimates and Forecasts by Application (2022-2027) 6.6.1 United States H2-Receptor Antagonists Sales Forecast by Application (2022-2027) 6.6.2 United States H2-Receptor Antagonists Revenue Forecast by Application (2022-2027) 6.6.3 United States H2-Receptor Antagonists Price Forecast by Application (2022-2027) 7 North America 7.1 North America H2-Receptor Antagonists Market Size YoY Growth 2016-2027 7.2 North America H2-Receptor Antagonists Market Facts & Figures by Country 7.2.1 North America H2-Receptor Antagonists Sales by Country (2016-2021) 7.2.2 North America H2-Receptor Antagonists Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific H2-Receptor Antagonists Market Size YoY Growth 2016-2027 8.2 Asia Pacific H2-Receptor Antagonists Market Facts & Figures by Region 8.2.1 Asia Pacific H2-Receptor Antagonists Sales by Region (2016-2021) 8.2.2 Asia Pacific H2-Receptor Antagonists Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe H2-Receptor Antagonists Market Size YoY Growth 2016-2027 9.2 Europe H2-Receptor Antagonists Market Facts & Figures by Country 9.2.1 Europe H2-Receptor Antagonists Sales by Country (2016-2021) 9.2.2 Europe H2-Receptor Antagonists Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America H2-Receptor Antagonists Market Size YoY Growth 2016-2027 10.2 Latin America H2-Receptor Antagonists Market Facts & Figures by Country 10.2.1 Latin America H2-Receptor Antagonists Sales by Country (2016-2021) 10.2.2 Latin America H2-Receptor Antagonists Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa H2-Receptor Antagonists Market Size YoY Growth 2016-2027 11.2 Middle East and Africa H2-Receptor Antagonists Market Facts & Figures by Country 11.2.1 Middle East and Africa H2-Receptor Antagonists Sales by Country (2016-2021) 11.2.2 Middle East and Africa H2-Receptor Antagonists Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Acic Pharmaceuticals 12.1.1 Acic Pharmaceuticals Corporation Information 12.1.2 Acic Pharmaceuticals Description and Business Overview 12.1.3 Acic Pharmaceuticals H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Acic Pharmaceuticals H2-Receptor Antagonists Products Offered 12.1.5 Acic Pharmaceuticals Recent Development 12.2 Actavis Mid Atlantic LLC 12.2.1 Actavis Mid Atlantic LLC Corporation Information 12.2.2 Actavis Mid Atlantic LLC Description and Business Overview 12.2.3 Actavis Mid Atlantic LLC H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Actavis Mid Atlantic LLC H2-Receptor Antagonists Products Offered 12.2.5 Actavis Mid Atlantic LLC Recent Development 12.3 Ajanta Pharma 12.3.1 Ajanta Pharma Corporation Information 12.3.2 Ajanta Pharma Description and Business Overview 12.3.3 Ajanta Pharma H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Ajanta Pharma H2-Receptor Antagonists Products Offered 12.3.5 Ajanta Pharma Recent Development 12.4 AmerisourceBergen 12.4.1 AmerisourceBergen Corporation Information 12.4.2 AmerisourceBergen Description and Business Overview 12.4.3 AmerisourceBergen H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.4.4 AmerisourceBergen H2-Receptor Antagonists Products Offered 12.4.5 AmerisourceBergen Recent Development 12.5 Amneal Pharmaceuticals 12.5.1 Amneal Pharmaceuticals Corporation Information 12.5.2 Amneal Pharmaceuticals Description and Business Overview 12.5.3 Amneal Pharmaceuticals H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Amneal Pharmaceuticals H2-Receptor Antagonists Products Offered 12.5.5 Amneal Pharmaceuticals Recent Development 12.6 ANDA Repository 12.6.1 ANDA Repository Corporation Information 12.6.2 ANDA Repository Description and Business Overview 12.6.3 ANDA Repository H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.6.4 ANDA Repository H2-Receptor Antagonists Products Offered 12.6.5 ANDA Repository Recent Development 12.7 Ani Pharmaceuticals 12.7.1 Ani Pharmaceuticals Corporation Information 12.7.2 Ani Pharmaceuticals Description and Business Overview 12.7.3 Ani Pharmaceuticals H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Ani Pharmaceuticals H2-Receptor Antagonists Products Offered 12.7.5 Ani Pharmaceuticals Recent Development 12.8 Apotex Inc. (and Apotex Corporation) 12.8.1 Apotex Inc. (and Apotex Corporation) Corporation Information 12.8.2 Apotex Inc. (and Apotex Corporation) Description and Business Overview 12.8.3 Apotex Inc. (and Apotex Corporation) H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Apotex Inc. (and Apotex Corporation) H2-Receptor Antagonists Products Offered 12.8.5 Apotex Inc. (and Apotex Corporation) Recent Development 12.9 Appco Pharma 12.9.1 Appco Pharma Corporation Information 12.9.2 Appco Pharma Description and Business Overview 12.9.3 Appco Pharma H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Appco Pharma H2-Receptor Antagonists Products Offered 12.9.5 Appco Pharma Recent Development 12.10 Aurobindo Pharma 12.10.1 Aurobindo Pharma Corporation Information 12.10.2 Aurobindo Pharma Description and Business Overview 12.10.3 Aurobindo Pharma H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Aurobindo Pharma H2-Receptor Antagonists Products Offered 12.10.5 Aurobindo Pharma Recent Development 12.11 Acic Pharmaceuticals 12.11.1 Acic Pharmaceuticals Corporation Information 12.11.2 Acic Pharmaceuticals Description and Business Overview 12.11.3 Acic Pharmaceuticals H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Acic Pharmaceuticals H2-Receptor Antagonists Products Offered 12.11.5 Acic Pharmaceuticals Recent Development 12.12 Boehringer Ingelheim 12.12.1 Boehringer Ingelheim Corporation Information 12.12.2 Boehringer Ingelheim Description and Business Overview 12.12.3 Boehringer Ingelheim H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Boehringer Ingelheim Products Offered 12.12.5 Boehringer Ingelheim Recent Development 12.13 Breckenridge Pharmaceuticals 12.13.1 Breckenridge Pharmaceuticals Corporation Information 12.13.2 Breckenridge Pharmaceuticals Description and Business Overview 12.13.3 Breckenridge Pharmaceuticals H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Breckenridge Pharmaceuticals Products Offered 12.13.5 Breckenridge Pharmaceuticals Recent Development 12.14 Contract Pharmacal Corp. 12.14.1 Contract Pharmacal Corp. Corporation Information 12.14.2 Contract Pharmacal Corp. Description and Business Overview 12.14.3 Contract Pharmacal Corp. H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Contract Pharmacal Corp. Products Offered 12.14.5 Contract Pharmacal Corp. Recent Development 12.15 Dr. Reddy's Laboratories Inc. 12.15.1 Dr. Reddy's Laboratories Inc. Corporation Information 12.15.2 Dr. Reddy's Laboratories Inc. Description and Business Overview 12.15.3 Dr. Reddy's Laboratories Inc. H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Dr. Reddy's Laboratories Inc. Products Offered 12.15.5 Dr. Reddy's Laboratories Inc. Recent Development 12.16 Geri-Care Pharmaceuticals 12.16.1 Geri-Care Pharmaceuticals Corporation Information 12.16.2 Geri-Care Pharmaceuticals Description and Business Overview 12.16.3 Geri-Care Pharmaceuticals H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Geri-Care Pharmaceuticals Products Offered 12.16.5 Geri-Care Pharmaceuticals Recent Development 12.17 GlaxoSmithKline 12.17.1 GlaxoSmithKline Corporation Information 12.17.2 GlaxoSmithKline Description and Business Overview 12.17.3 GlaxoSmithKline H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.17.4 GlaxoSmithKline Products Offered 12.17.5 GlaxoSmithKline Recent Development 12.18 Glenmark Pharmaceuticals 12.18.1 Glenmark Pharmaceuticals Corporation Information 12.18.2 Glenmark Pharmaceuticals Description and Business Overview 12.18.3 Glenmark Pharmaceuticals H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.18.4 Glenmark Pharmaceuticals Products Offered 12.18.5 Glenmark Pharmaceuticals Recent Development 12.19 Granules Pharmaceuticals Inc. 12.19.1 Granules Pharmaceuticals Inc. Corporation Information 12.19.2 Granules Pharmaceuticals Inc. Description and Business Overview 12.19.3 Granules Pharmaceuticals Inc. H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.19.4 Granules Pharmaceuticals Inc. Products Offered 12.19.5 Granules Pharmaceuticals Inc. Recent Development 12.20 Heritage Pharma Labs Inc. 12.20.1 Heritage Pharma Labs Inc. Corporation Information 12.20.2 Heritage Pharma Labs Inc. Description and Business Overview 12.20.3 Heritage Pharma Labs Inc. H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.20.4 Heritage Pharma Labs Inc. Products Offered 12.20.5 Heritage Pharma Labs Inc. Recent Development 12.21 Hikma Pharmaceuticals 12.21.1 Hikma Pharmaceuticals Corporation Information 12.21.2 Hikma Pharmaceuticals Description and Business Overview 12.21.3 Hikma Pharmaceuticals H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.21.4 Hikma Pharmaceuticals Products Offered 12.21.5 Hikma Pharmaceuticals Recent Development 12.22 Hi-Tech Pharmacal Co. 12.22.1 Hi-Tech Pharmacal Co. Corporation Information 12.22.2 Hi-Tech Pharmacal Co. Description and Business Overview 12.22.3 Hi-Tech Pharmacal Co. H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.22.4 Hi-Tech Pharmacal Co. Products Offered 12.22.5 Hi-Tech Pharmacal Co. Recent Development 12.23 Lannett Co. 12.23.1 Lannett Co. Corporation Information 12.23.2 Lannett Co. Description and Business Overview 12.23.3 Lannett Co. H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.23.4 Lannett Co. Products Offered 12.23.5 Lannett Co. Recent Development 12.24 Mylan Pharmaceuticals Inc. 12.24.1 Mylan Pharmaceuticals Inc. Corporation Information 12.24.2 Mylan Pharmaceuticals Inc. Description and Business Overview 12.24.3 Mylan Pharmaceuticals Inc. H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.24.4 Mylan Pharmaceuticals Inc. Products Offered 12.24.5 Mylan Pharmaceuticals Inc. Recent Development 12.25 Nostrum Laboratories Inc. 12.25.1 Nostrum Laboratories Inc. Corporation Information 12.25.2 Nostrum Laboratories Inc. Description and Business Overview 12.25.3 Nostrum Laboratories Inc. H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.25.4 Nostrum Laboratories Inc. Products Offered 12.25.5 Nostrum Laboratories Inc. Recent Development 12.26 Novitium Pharma 12.26.1 Novitium Pharma Corporation Information 12.26.2 Novitium Pharma Description and Business Overview 12.26.3 Novitium Pharma H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.26.4 Novitium Pharma Products Offered 12.26.5 Novitium Pharma Recent Development 12.27 PAI Holdings, LLC 12.27.1 PAI Holdings, LLC Corporation Information 12.27.2 PAI Holdings, LLC Description and Business Overview 12.27.3 PAI Holdings, LLC H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.27.4 PAI Holdings, LLC Products Offered 12.27.5 PAI Holdings, LLC Recent Development 12.28 Par Pharmaceutical Inc. 12.28.1 Par Pharmaceutical Inc. Corporation Information 12.28.2 Par Pharmaceutical Inc. Description and Business Overview 12.28.3 Par Pharmaceutical Inc. H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.28.4 Par Pharmaceutical Inc. Products Offered 12.28.5 Par Pharmaceutical Inc. Recent Development 12.29 Perrigo 12.29.1 Perrigo Corporation Information 12.29.2 Perrigo Description and Business Overview 12.29.3 Perrigo H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.29.4 Perrigo Products Offered 12.29.5 Perrigo Recent Development 12.30 Ranbaxy Inc. 12.30.1 Ranbaxy Inc. Corporation Information 12.30.2 Ranbaxy Inc. Description and Business Overview 12.30.3 Ranbaxy Inc. H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.30.4 Ranbaxy Inc. Products Offered 12.30.5 Ranbaxy Inc. Recent Development 12.31 Sandoz Inc. 12.31.1 Sandoz Inc. Corporation Information 12.31.2 Sandoz Inc. Description and Business Overview 12.31.3 Sandoz Inc. H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.31.4 Sandoz Inc. Products Offered 12.31.5 Sandoz Inc. Recent Development 12.32 Sanofi-Aventis 12.32.1 Sanofi-Aventis Corporation Information 12.32.2 Sanofi-Aventis Description and Business Overview 12.32.3 Sanofi-Aventis H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.32.4 Sanofi-Aventis Products Offered 12.32.5 Sanofi-Aventis Recent Development 12.33 Strides 12.33.1 Strides Corporation Information 12.33.2 Strides Description and Business Overview 12.33.3 Strides H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.33.4 Strides Products Offered 12.33.5 Strides Recent Development 12.34 Sun Pharma 12.34.1 Sun Pharma Corporation Information 12.34.2 Sun Pharma Description and Business Overview 12.34.3 Sun Pharma H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.34.4 Sun Pharma Products Offered 12.34.5 Sun Pharma Recent Development 12.35 Taro Pharmaceuticals 12.35.1 Taro Pharmaceuticals Corporation Information 12.35.2 Taro Pharmaceuticals Description and Business Overview 12.35.3 Taro Pharmaceuticals H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.35.4 Taro Pharmaceuticals Products Offered 12.35.5 Taro Pharmaceuticals Recent Development 12.36 Teva Pharmaceuticals 12.36.1 Teva Pharmaceuticals Corporation Information 12.36.2 Teva Pharmaceuticals Description and Business Overview 12.36.3 Teva Pharmaceuticals H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.36.4 Teva Pharmaceuticals Products Offered 12.36.5 Teva Pharmaceuticals Recent Development 12.37 Thirty Madison 12.37.1 Thirty Madison Corporation Information 12.37.2 Thirty Madison Description and Business Overview 12.37.3 Thirty Madison H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.37.4 Thirty Madison Products Offered 12.37.5 Thirty Madison Recent Development 12.38 Torrent Pharma 12.38.1 Torrent Pharma Corporation Information 12.38.2 Torrent Pharma Description and Business Overview 12.38.3 Torrent Pharma H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.38.4 Torrent Pharma Products Offered 12.38.5 Torrent Pharma Recent Development 12.39 Unique Pharmaceutical Laboratories 12.39.1 Unique Pharmaceutical Laboratories Corporation Information 12.39.2 Unique Pharmaceutical Laboratories Description and Business Overview 12.39.3 Unique Pharmaceutical Laboratories H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.39.4 Unique Pharmaceutical Laboratories Products Offered 12.39.5 Unique Pharmaceutical Laboratories Recent Development 12.40 VKT Pharma 12.40.1 VKT Pharma Corporation Information 12.40.2 VKT Pharma Description and Business Overview 12.40.3 VKT Pharma H2-Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021) 12.40.4 VKT Pharma Products Offered 12.40.5 VKT Pharma Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 H2-Receptor Antagonists Industry Trends 13.2 H2-Receptor Antagonists Market Drivers 13.3 H2-Receptor Antagonists Market Challenges 13.4 H2-Receptor Antagonists Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 H2-Receptor Antagonists Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global H2-Receptor Antagonists Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Ranitidine/Zantac Table 3. Major Manufacturers of Cimetidine Table 4. Major Manufacturers of Famotidine Table 5. Major Manufacturers of Nazatidine Table 6. Global H2-Receptor Antagonists Market Size Growth Rate by Application (2021-2027) & (K Units) Table 7. Global H2-Receptor Antagonists Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 8. Global H2-Receptor Antagonists Sales by Regions (2016-2021) & (K Units) Table 9. Global H2-Receptor Antagonists Sales Market Share by Regions (2016-2021) Table 10. Global H2-Receptor Antagonists Revenue by Regions (2016-2021) & (US$ Million) Table 11. Global H2-Receptor Antagonists Sales Forecast by Region (2022-2027) & (K Units) Table 12. Global H2-Receptor Antagonists Sales Market Share Forecast by Region (2022-2027) Table 13. Global H2-Receptor Antagonists Revenue Forecast by Region (2022-2027) & (US$ Million) Table 14. Global H2-Receptor Antagonists Revenue Market Share Forecast by Region (2022-2027) Table 15. Global H2-Receptor Antagonists Sales by Manufacturers (2016-2021) (K Units) Table 16. Global H2-Receptor Antagonists Sales Share by Manufacturers (2016-2021) Table 17. Ranking of Global Top H2-Receptor Antagonists Manufacturers by Revenue (US$ Million) in 2020 Table 18. H2-Receptor Antagonists Revenue by Manufacturers (2016-2021) (US$ Million) Table 19. H2-Receptor Antagonists Revenue Share by Manufacturers (2016-2021) Table 20. Global H2-Receptor Antagonists Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 21. Global H2-Receptor Antagonists by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in H2-Receptor Antagonists as of 2020) Table 22. Key Manufacturers H2-Receptor Antagonists Price (2016-2021) (US$/Unit) Table 23. H2-Receptor Antagonists Manufacturers Manufacturing Base Distribution and Headquarters Table 24. Manufacturers H2-Receptor Antagonists Product Type Table 25. Date of International Manufacturers Enter into H2-Receptor Antagonists Market Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans Table 27. Global H2-Receptor Antagonists Sales by Type (2016-2021) (K Units) Table 28. Global H2-Receptor Antagonists Sales Share by Type (2016-2021) Table 29. Global H2-Receptor Antagonists Revenue by Type (2016-2021) (US$ Million) Table 30. Global H2-Receptor Antagonists Revenue Share by Type (2016-2021) Table 31. H2-Receptor Antagonists Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit) Table 32. Global H2-Receptor Antagonists Sales Forecast by Type (2022-2027) & (K Units) Table 33. Global H2-Receptor Antagonists Sales Market Share Forecast by Type (2022-2027) Table 34. Global H2-Receptor Antagonists Revenue Forecast V (2022-2027) & (US$ Million) Table 35. Global H2-Receptor Antagonists Revenue Market Share Forecast by Type (2022-2027) Table 36. Global H2-Receptor Antagonists Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit) Table 37. Global H2-Receptor Antagonists Sales by Application (2016-2021) (K Units) Table 38. Global H2-Receptor Antagonists Sales Share by Application (2016-2021) Table 39. Global H2-Receptor Antagonists Revenue by Application (2016-2021) (US$ Million) Table 40. Global H2-Receptor Antagonists Revenue Share by Application (2016-2021) Table 41. H2-Receptor Antagonists Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit) Table 42. Global H2-Receptor Antagonists Sales Forecast by Application (2022-2027) & (K Units) Table 43. Global H2-Receptor Antagonists Sales Market Share Forecast by Application (2022-2027) Table 44. Global H2-Receptor Antagonists Revenue Forecast by Application (2022-2027) & (US$ Million) Table 45. Global H2-Receptor Antagonists Revenue Market Share Forecast by Application (2022-2027) Table 46. Global H2-Receptor Antagonists Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit) Table 47. United States H2-Receptor Antagonists Sales (K Units) of Key Companies (2016-2021) Table 48. United States H2-Receptor Antagonists Sales Share by Company (2016-2021) Table 49. United States H2-Receptor Antagonists Revenue (US$ Million) by Company (2016-2021) Table 50. United States H2-Receptor Antagonists Revenue Share by Company (2016-2021) Table 51. United States H2-Receptor Antagonists Sales (K Units) by Type (2016-2021) Table 52. United States H2-Receptor Antagonists Sales Share by Type (2016-2021) Table 53. United States H2-Receptor Antagonists Revenue (US$ Million) Market Share by Type (2016-2021) Table 54. United States H2-Receptor Antagonists Price (US$/Unit) by Type (2016-2021) Table 55. United States H2-Receptor Antagonists Sales (K Units) by Type (2022-2027) Table 56. United States H2-Receptor Antagonists Sales Share by Type (2022-2027) Table 57. United States H2-Receptor Antagonists Revenue (US$ Million) Market Share by Type (2022-2027) Table 58. United States H2-Receptor Antagonists Revenue Share by Type (2022-2027) Table 59. United States H2-Receptor Antagonists Price (US$/Unit) by Type (2022-2027) Table 60. United States H2-Receptor Antagonists Sales (K Units) by Application (2016-2021) Table 61. United States H2-Receptor Antagonists Sales Share by Application (2016-2021) Table 62. United States H2-Receptor Antagonists Revenue (US$ Million) Market Share by Application (2016-2021) Table 63. United States H2-Receptor Antagonists Price (US$/Unit) by Application (2016-2021) Table 64. United States H2-Receptor Antagonists Sales (K Units) by Application (2022-2027) Table 65. United States H2-Receptor Antagonists Sales Share by Application (2022-2027) Table 66. United States H2-Receptor Antagonists Revenue (US$ Million) Market Share by Application (2022-2027) Table 67. United States H2-Receptor Antagonists Revenue Share by Application (2022-2027) Table 68. United States H2-Receptor Antagonists Price (US$/Unit) by Application (2022-2027) Table 69. North America H2-Receptor Antagonists Sales by Country (2016-2021) & (K Units) Table 70. North America H2-Receptor Antagonists Sales Market Share by Country (2016-2021) Table 71. North America H2-Receptor Antagonists Revenue by Country (2016-2021) & (US$ Million) Table 72. North America H2-Receptor Antagonists Revenue Market Share by Country (2016-2021) Table 73. Asia Pacific H2-Receptor Antagonists Sales by Region (2016-2021) & (K Units) Table 74. Asia Pacific H2-Receptor Antagonists Sales Market Share by Region (2016-2021) Table 75. Asia Pacific H2-Receptor Antagonists Revenue by Region (2016-2021) & (US$ Million) Table 76. Asia Pacific H2-Receptor Antagonists Revenue Market Share by Region (2016-2021) Table 77. Europe H2-Receptor Antagonists Sales by Country (2016-2021) & (K Units) Table 78. Europe H2-Receptor Antagonists Sales Market Share by Country (2016-2021) Table 79. Europe H2-Receptor Antagonists Revenue by Country (2016-2021) & (US$ Million) Table 80. Europe H2-Receptor Antagonists Revenue Market Share by Country (2016-2021) Table 81. Latin America H2-Receptor Antagonists Sales by Country (2016-2021) & (K Units) Table 82. Latin America H2-Receptor Antagonists Sales Market Share by Country (2016-2021) Table 83. Latin Americaa H2-Receptor Antagonists Revenue by Country (2016-2021) & (US$ Million) Table 84. Latin America H2-Receptor Antagonists Revenue Market Share by Country (2016-2021) Table 85. Middle East and Africa H2-Receptor Antagonists Sales by Country (2016-2021) & (K Units) Table 86. Middle East and Africa H2-Receptor Antagonists Sales Market Share by Country (2016-2021) Table 87. Middle East and Africa H2-Receptor Antagonists Revenue by Country (2016-2021) & (US$ Million) Table 88. Middle East and Africa H2-Receptor Antagonists Revenue Market Share by Country (2016-2021) Table 89. Acic Pharmaceuticals Corporation Information Table 90. Acic Pharmaceuticals Description and Business Overview Table 91. Acic Pharmaceuticals H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 92. Acic Pharmaceuticals H2-Receptor Antagonists Product Table 93. Acic Pharmaceuticals Recent Development Table 94. Actavis Mid Atlantic LLC Corporation Information Table 95. Actavis Mid Atlantic LLC Description and Business Overview Table 96. Actavis Mid Atlantic LLC H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 97. Actavis Mid Atlantic LLC Product Table 98. Actavis Mid Atlantic LLC Recent Development Table 99. Ajanta Pharma Corporation Information Table 100. Ajanta Pharma Description and Business Overview Table 101. Ajanta Pharma H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 102. Ajanta Pharma Product Table 103. Ajanta Pharma Recent Development Table 104. AmerisourceBergen Corporation Information Table 105. AmerisourceBergen Description and Business Overview Table 106. AmerisourceBergen H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 107. AmerisourceBergen Product Table 108. AmerisourceBergen Recent Development Table 109. Amneal Pharmaceuticals Corporation Information Table 110. Amneal Pharmaceuticals Description and Business Overview Table 111. Amneal Pharmaceuticals H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 112. Amneal Pharmaceuticals Product Table 113. Amneal Pharmaceuticals Recent Development Table 114. ANDA Repository Corporation Information Table 115. ANDA Repository Description and Business Overview Table 116. ANDA Repository H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 117. ANDA Repository Product Table 118. ANDA Repository Recent Development Table 119. Ani Pharmaceuticals Corporation Information Table 120. Ani Pharmaceuticals Description and Business Overview Table 121. Ani Pharmaceuticals H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 122. Ani Pharmaceuticals Product Table 123. Ani Pharmaceuticals Recent Development Table 124. Apotex Inc. (and Apotex Corporation) Corporation Information Table 125. Apotex Inc. (and Apotex Corporation) Description and Business Overview Table 126. Apotex Inc. (and Apotex Corporation) H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 127. Apotex Inc. (and Apotex Corporation) Product Table 128. Apotex Inc. (and Apotex Corporation) Recent Development Table 129. Appco Pharma Corporation Information Table 130. Appco Pharma Description and Business Overview Table 131. Appco Pharma H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 132. Appco Pharma Product Table 133. Appco Pharma Recent Development Table 134. Aurobindo Pharma Corporation Information Table 135. Aurobindo Pharma Description and Business Overview Table 136. Aurobindo Pharma H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 137. Aurobindo Pharma Product Table 138. Aurobindo Pharma Recent Development Table 139. Ben Venue Laboratories Inc. Corporation Information Table 140. Ben Venue Laboratories Inc. Description and Business Overview Table 141. Ben Venue Laboratories Inc. H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 142. Ben Venue Laboratories Inc. Product Table 143. Ben Venue Laboratories Inc. Recent Development Table 144. Boehringer Ingelheim Corporation Information Table 145. Boehringer Ingelheim Description and Business Overview Table 146. Boehringer Ingelheim H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 147. Boehringer Ingelheim Product Table 148. Boehringer Ingelheim Recent Development Table 149. Breckenridge Pharmaceuticals Corporation Information Table 150. Breckenridge Pharmaceuticals Description and Business Overview Table 151. Breckenridge Pharmaceuticals H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 152. Breckenridge Pharmaceuticals Product Table 153. Breckenridge Pharmaceuticals Recent Development Table 154. Contract Pharmacal Corp. Corporation Information Table 155. Contract Pharmacal Corp. Description and Business Overview Table 156. Contract Pharmacal Corp. H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 157. Contract Pharmacal Corp. Product Table 158. Contract Pharmacal Corp. Recent Development Table 159. Dr. Reddy's Laboratories Inc. Corporation Information Table 160. Dr. Reddy's Laboratories Inc. Description and Business Overview Table 161. Dr. Reddy's Laboratories Inc. H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 162. Dr. Reddy's Laboratories Inc. Product Table 163. Dr. Reddy's Laboratories Inc. Recent Development Table 164. Geri-Care Pharmaceuticals Corporation Information Table 165. Geri-Care Pharmaceuticals Description and Business Overview Table 166. Geri-Care Pharmaceuticals H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 167. Geri-Care Pharmaceuticals Product Table 168. Geri-Care Pharmaceuticals Recent Development Table 169. GlaxoSmithKline Corporation Information Table 170. GlaxoSmithKline Description and Business Overview Table 171. GlaxoSmithKline H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 172. GlaxoSmithKline Product Table 173. GlaxoSmithKline Recent Development Table 174. Glenmark Pharmaceuticals Corporation Information Table 175. Glenmark Pharmaceuticals Description and Business Overview Table 176. Glenmark Pharmaceuticals H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 177. Glenmark Pharmaceuticals Product Table 178. Glenmark Pharmaceuticals Recent Development Table 179. Granules Pharmaceuticals Inc. Corporation Information Table 180. Granules Pharmaceuticals Inc. Description and Business Overview Table 181. Granules Pharmaceuticals Inc. H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 182. Granules Pharmaceuticals Inc. Product Table 183. Granules Pharmaceuticals Inc. Recent Development Table 184. Heritage Pharma Labs Inc. Corporation Information Table 185. Heritage Pharma Labs Inc. Description and Business Overview Table 186. Heritage Pharma Labs Inc. H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 187. Heritage Pharma Labs Inc. Product Table 188. Heritage Pharma Labs Inc. Recent Development Table 189. Hikma Pharmaceuticals Corporation Information Table 190. Hikma Pharmaceuticals Description and Business Overview Table 191. Hikma Pharmaceuticals H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 192. Hikma Pharmaceuticals Product Table 193. Hikma Pharmaceuticals Recent Development Table 194. Hi-Tech Pharmacal Co. Corporation Information Table 195. Hi-Tech Pharmacal Co. Description and Business Overview Table 196. Hi-Tech Pharmacal Co. H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 197. Hi-Tech Pharmacal Co. Product Table 198. Hi-Tech Pharmacal Co. Recent Development Table 199. Lannett Co. Corporation Information Table 200. Lannett Co. Description and Business Overview Table 201. Lannett Co. H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 202. Lannett Co. Product Table 203. Lannett Co. Recent Development Table 204. Mylan Pharmaceuticals Inc. Corporation Information Table 205. Mylan Pharmaceuticals Inc. Description and Business Overview Table 206. Mylan Pharmaceuticals Inc. H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 207. Mylan Pharmaceuticals Inc. Product Table 208. Mylan Pharmaceuticals Inc. Recent Development Table 209. Nostrum Laboratories Inc. Corporation Information Table 210. Nostrum Laboratories Inc. Description and Business Overview Table 211. Nostrum Laboratories Inc. H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 212. Nostrum Laboratories Inc. Product Table 213. Nostrum Laboratories Inc. Recent Development Table 214. Novitium Pharma Corporation Information Table 215. Novitium Pharma Description and Business Overview Table 216. Novitium Pharma H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 217. Novitium Pharma Product Table 218. Novitium Pharma Recent Development Table 219. PAI Holdings, LLC Corporation Information Table 220. PAI Holdings, LLC Description and Business Overview Table 221. PAI Holdings, LLC H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 222. PAI Holdings, LLC Product Table 223. PAI Holdings, LLC Recent Development Table 224. Par Pharmaceutical Inc. Corporation Information Table 225. Par Pharmaceutical Inc. Description and Business Overview Table 226. Par Pharmaceutical Inc. H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 227. Par Pharmaceutical Inc. Product Table 228. Par Pharmaceutical Inc. Recent Development Table 229. Perrigo Corporation Information Table 230. Perrigo Description and Business Overview Table 231. Perrigo H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 232. Perrigo Product Table 233. Perrigo Recent Development Table 234. Ranbaxy Inc. Corporation Information Table 235. Ranbaxy Inc. Description and Business Overview Table 236. Ranbaxy Inc. H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 237. Ranbaxy Inc. Product Table 238. Ranbaxy Inc. Recent Development Table 239. Sandoz Inc. Corporation Information Table 240. Sandoz Inc. Description and Business Overview Table 241. Sandoz Inc. H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 242. Sandoz Inc. Product Table 243. Sandoz Inc. Recent Development Table 244. Sanofi-Aventis Corporation Information Table 245. Sanofi-Aventis Description and Business Overview Table 246. Sanofi-Aventis H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 247. Sanofi-Aventis Product Table 248. Sanofi-Aventis Recent Development Table 249. Strides Corporation Information Table 250. Strides Description and Business Overview Table 251. Strides H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 252. Strides Product Table 253. Strides Recent Development Table 254. Sun Pharma Corporation Information Table 255. Sun Pharma Description and Business Overview Table 256. Sun Pharma H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 257. Sun Pharma Product Table 258. Sun Pharma Recent Development Table 259. Taro Pharmaceuticals Corporation Information Table 260. Taro Pharmaceuticals Description and Business Overview Table 261. Taro Pharmaceuticals H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 262. Taro Pharmaceuticals Product Table 263. Taro Pharmaceuticals Recent Development Table 264. Teva Pharmaceuticals Corporation Information Table 265. Teva Pharmaceuticals Description and Business Overview Table 266. Teva Pharmaceuticals H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 267. Teva Pharmaceuticals Product Table 268. Teva Pharmaceuticals Recent Development Table 269. Thirty Madison Corporation Information Table 270. Thirty Madison Description and Business Overview Table 271. Thirty Madison H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 272. Thirty Madison Product Table 273. Thirty Madison Recent Development Table 274. Torrent Pharma Corporation Information Table 275. Torrent Pharma Description and Business Overview Table 276. Torrent Pharma H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 277. Torrent Pharma Product Table 278. Torrent Pharma Recent Development Table 279. Unique Pharmaceutical Laboratories Corporation Information Table 280. Unique Pharmaceutical Laboratories Description and Business Overview Table 281. Unique Pharmaceutical Laboratories H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 282. Unique Pharmaceutical Laboratories Product Table 283. Unique Pharmaceutical Laboratories Recent Development Table 284. VKT Pharma Corporation Information Table 285. VKT Pharma Description and Business Overview Table 286. VKT Pharma H2-Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 287. VKT Pharma Product Table 288. VKT Pharma Recent Development Table 289. H2-Receptor Antagonists Market Trends Table 290. H2-Receptor Antagonists Market Drivers Table 291. H2-Receptor Antagonists Market Challenges Table 292. H2-Receptor Antagonists Market Restraints Table 293. H2-Receptor Antagonists Customers List Table 294. H2-Receptor Antagonists Distributors List Table 295. Research Programs/Design for This Report Table 296. Key Data Information from Secondary Sources Table 297. Key Data Information from Primary Sources List of Figures Figure 1. H2-Receptor Antagonists Product Picture Figure 2. Global H2-Receptor Antagonists Sales Market Share by Type in 2020 & 2027 Figure 3. Ranitidine/Zantac Product Picture Figure 4. Cimetidine Product Picture Figure 5. Famotidine Product Picture Figure 6. Nazatidine Product Picture Figure 7. Global H2-Receptor Antagonists Sales Market Share by Application in 2020 & 2027 Figure 8. Retail Stores Figure 9. Clinics Figure 10. Hospitals Figure 11. OTC Sales Figure 12. H2-Receptor Antagonists Report Years Considered Figure 13. Global H2-Receptor Antagonists Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global H2-Receptor Antagonists Market Size 2016-2027 (US$ Million) Figure 15. Global H2-Receptor Antagonists Sales 2016-2027 (K Units) Figure 16. Global H2-Receptor Antagonists Market Size Market Share by Region: 2021 Versus 2027 Figure 17. Global H2-Receptor Antagonists Sales Market Share by Region (2016-2021) Figure 18. Global H2-Receptor Antagonists Sales Market Share by Region in 2020 Figure 19. Global H2-Receptor Antagonists Revenue Market Share by Region (2016-2021) Figure 20. Global H2-Receptor Antagonists Revenue Market Share by Region in 2020 Figure 21. Global H2-Receptor Antagonists Sales Share by Manufacturer in 2020 Figure 22. The Top 10 and 5 Players Market Share by H2-Receptor Antagonists Revenue in 2020 Figure 23. H2-Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 24. Global H2-Receptor Antagonists Sales Market Share by Type (2016-2021) Figure 25. Global H2-Receptor Antagonists Sales Market Share by Type in 2020 Figure 26. Global H2-Receptor Antagonists Revenue Market Share by Type (2016-2021) Figure 27. Global H2-Receptor Antagonists Revenue Market Share by Type in 2020 Figure 28. Global H2-Receptor Antagonists Sales Market Share by Application (2016-2021) Figure 29. Global H2-Receptor Antagonists Sales Market Share by Application in 2020 Figure 30. Global H2-Receptor Antagonists Revenue Market Share by Application (2016-2021) Figure 31. Global H2-Receptor Antagonists Revenue Market Share by Application in 2020 Figure 32. United States H2-Receptor Antagonists Sales Growth Rate 2016-2027 (K Units) Figure 33. United States H2-Receptor Antagonists Revenue Growth Rate 2016-2027 (US$ Million) Figure 34. United States H2-Receptor Antagonists Market Share in Global Market 2016-2027 Figure 35. United States 5 and 10 Largest H2-Receptor Antagonists Players Market Share by Revenue in H2-Receptor Antagonists in 2020 Figure 36. United States H2-Receptor Antagonists Revenue Share by Type (2016-2021) Figure 37. United States H2-Receptor Antagonists Revenue Growth Rate by Type in 2016 & 2020 Figure 38. United States H2-Receptor Antagonists Revenue Share by Application (2016-2021) Figure 39. United States H2-Receptor Antagonists Revenue Growth Rate by Application in 2016 & 2020 Figure 40. North America H2-Receptor Antagonists Sales Growth Rate 2016-2021 (K Units) Figure 41. North America H2-Receptor Antagonists Revenue Growth Rate 2016-2021 (US$ Million) Figure 42. North America H2-Receptor Antagonists Sales Market Share by Country in 2020 Figure 43. North America H2-Receptor Antagonists Revenue Market Share by Country in 2020 Figure 44. U.S. H2-Receptor Antagonists Sales Growth Rate (2016-2021) (K Units) Figure 45. U.S. H2-Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Canada H2-Receptor Antagonists Sales Growth Rate (2016-2021) (K Units) Figure 47. Canada H2-Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Europe H2-Receptor Antagonists Sales Growth Rate 2016-2021 (K Units) Figure 49. Europe H2-Receptor Antagonists Revenue Growth Rate 2016-2021 (US$ Million) Figure 50. Europe H2-Receptor Antagonists Sales Market Share by Country in 2020 Figure 51. Europe H2-Receptor Antagonists Revenue Market Share by Country in 2020 Figure 52. Germany H2-Receptor Antagonists Sales Growth Rate (2016-2021) (K Units) Figure 53. Germany H2-Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 54. France H2-Receptor Antagonists Sales Growth Rate (2016-2021) (K Units) Figure 55. France H2-Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 56. U.K. H2-Receptor Antagonists Sales Growth Rate (2016-2021) (K Units) Figure 57. U.K. H2-Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 58. Italy H2-Receptor Antagonists Sales Growth Rate (2016-2021) (K Units) Figure 59. Italy H2-Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 60. Russia H2-Receptor Antagonists Sales Growth Rate (2016-2021) (K Units) Figure 61. Russia H2-Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 62. Asia Pacific H2-Receptor Antagonists Sales Growth Rate 2016-2021 (K Units) Figure 63. Asia Pacific H2-Receptor Antagonists Revenue Growth Rate 2016-2021 (US$ Million) Figure 64. Asia Pacific H2-Receptor Antagonists Sales Market Share by Region in 2020 Figure 65. Asia Pacific H2-Receptor Antagonists Revenue Market Share by Region in 2020 Figure 66. China H2-Receptor Antagonists Sales Growth Rate (2016-2021) (K Units) Figure 67. China H2-Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 68. Japan H2-Receptor Antagonists Sales Growth Rate (2016-2021) (K Units) Figure 69. Japan H2-Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 70. South Korea H2-Receptor Antagonists Sales Growth Rate (2016-2021) (K Units) Figure 71. South Korea H2-Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 72. India H2-Receptor Antagonists Sales Growth Rate (2016-2021) (K Units) Figure 73. India H2-Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 74. Australia H2-Receptor Antagonists Sales Growth Rate (2016-2021) (K Units) Figure 75. Australia H2-Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 76. Taiwan H2-Receptor Antagonists Sales Growth Rate (2016-2021) (K Units) Figure 77. Taiwan H2-Receptor Antagonists Revenue Growth Rate (2016-2021) (US$ Million) Figure 78. Indonesia H2-Receptor Antagonists Sales Growth Rate (2016-2021) (K Units)_x000

Acic Pharmaceuticals Actavis Mid Atlantic LLC Ajanta Pharma AmerisourceBergen Amneal Pharmaceuticals ANDA Repository Ani Pharmaceuticals Apotex Inc. (and Apotex Corporation) Appco Pharma Aurobindo Pharma Ben Venue Laboratories Inc. Boehringer Ingelheim Breckenridge Pharmaceuticals Contract Pharmacal Corp. Dr. Reddy's Laboratories Inc. Geri-Care Pharmaceuticals GlaxoSmithKline Glenmark Pharmaceuticals Granules Pharmaceuticals Inc. Heritage Pharma Labs Inc. Hikma Pharmaceuticals Hi-Tech Pharmacal Co. Lannett Co. Mylan Pharmaceuticals Inc. Nostrum Laboratories Inc. Novitium Pharma PAI Holdings, LLC Par Pharmaceutical Inc. Perrigo Ranbaxy Inc. Sandoz Inc. Sanofi-Aventis Strides Sun Pharma Taro Pharmaceuticals Teva Pharmaceuticals Thirty Madison Torrent Pharma Unique Pharmaceutical Laboratories VKT Pharma